España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Incannex Healthcare
IXHL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.00
-0.34
-14.53%
At close: -
$2.00
0
0.00%
After Hours: Nov 15, 5:46 PM EDT
Get Report
Comment
Q1 2025 Earnings were released on Thu Nov 14th, after the market close
Incannex Healthcare (IXHL) Forecast
News
Earnings
Incannex Healthcare (IXHL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Incannex Healthcare (NASDAQ:IXHL) Stock
Incannex Healthcare Stock (NASDAQ: IXHL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
Incannex Healthcare Q1 EPS $(0.29) Down From ...
Benzinga Newsdesk
Tuesday, October 01, 2024
Incannex Healthcare shares are trading lower ...
Benzinga Newsdesk
Monday, September 30, 2024
Incannex Healthcare FY24 EPS $(1.15) Vs $(3.3...
Benzinga Newsdesk
Tuesday, September 10, 2024
Incannex Secures $60M Financing To Drive Advances In Psychedelic And Cannabinoid Therapies
Patricio Liddle
Incannex Healthcare Entered Agreement To Issu...
Benzinga Newsdesk
Monday, August 05, 2024
FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety
Juan Spínelli
Incannex to Launch FDA-Approved Psilocybin Tr...
Benzinga Newsdesk
Wednesday, July 17, 2024
Incannex Healthcare Files For Offering Of 4M ...
Benzinga Newsdesk
Thursday, May 30, 2024
Incannex Healthcare Commences Dosing In Phase...
Benzinga Newsdesk
Tuesday, May 07, 2024
FDA Experts Weigh In On Incannex's CannQuit-O With Feedback On CBD As Treatment For Opioid Use Disorder
Jelena Martinovic
Incannex Complete Successful Pre-IND Meeting ...
Benzinga Newsdesk
Wednesday, April 17, 2024
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
Friday, March 29, 2024
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein
Friday, March 22, 2024
Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
Abbey Higginbotham
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
Thursday, March 14, 2024
Reported Earlier, 'Indiana Lawmakers Send Psi...
Benzinga Newsdesk
Tuesday, March 05, 2024
Incannex Healthcare Tapped Treasurer and Cont...
Benzinga Newsdesk
Monday, March 04, 2024
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein
Wednesday, February 28, 2024
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
Lara Goldstein
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
What's Going On With Incannex Stock?
Erica Kollmann
Incannex Healthcare Shares Resume Trade
Benzinga Newsdesk
Incannex Healthcare Shares Halted On Circuit ...
Benzinga Newsdesk
Incannex shares are trading higher after the ...
Benzinga Newsdesk
Market-Moving News for February 28th
Benzinga Newsdesk
Incannex Announces Topline Results from Phase...
Benzinga Newsdesk
Wednesday, February 21, 2024
Incannex Healthcare Shares Resume Trade
Benzinga Newsdesk
Incannex Healthcare Shares Halted On Circuit ...
Benzinga Newsdesk
Friday, February 16, 2024
Incannex Said It Completes Successful Pre-IND...
Benzinga Newsdesk
Thursday, February 15, 2024
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Lara Goldstein
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Lara Goldstein
Saturday, January 27, 2024
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Lara Goldstein
Thursday, January 25, 2024
Podcast: International Cannabis And Psychedelics Co. Is Working 'Hand In Hand' With FDA To Forge New Therapy Frontiers
Lara Goldstein
Wednesday, January 24, 2024
Incannex Commences Dosing In Phase 2 Clinical...
Benzinga Newsdesk
Thursday, January 18, 2024
Incannex Completes Dosing And Therapy In Phas...
Benzinga Newsdesk
Wednesday, January 17, 2024
Incannex Received IRB Approval For RePOSA Phase 2/3 Clinical Trial Protocol To Assess IHL-42X Drug In Patients With Obstructive Sleep Apnea
Charles Gross
Friday, January 12, 2024
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Lara Goldstein
Monday, January 08, 2024
Psyched: Psychedelics For Brain Injury, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, $50M For Atai And More
Lara Goldstein
Friday, December 29, 2023
Global Mofy Metaverse Reports Follow-on Offering, Joins Lyft, Coinbase Global And Other Big Stocks Moving Lower On Friday
Avi Kapoor
Wednesday, December 27, 2023
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Lara Goldstein
Friday, December 22, 2023
Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia
Lara Goldstein
Monday, December 18, 2023
Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
Lara Goldstein
Tuesday, December 12, 2023
Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Monday, December 11, 2023
Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
Lara Goldstein
Wednesday, December 06, 2023
Incannex Healthcare shares are trading lower....
Benzinga Newsdesk
Incannex Says Results Of Proof-Of-Concept Stu...
Benzinga Newsdesk
Incannex Healthcare Provides Update On IHL-42...
Benzinga Newsdesk
Box Reports Weak Q3 Results, Joins Yext, Asana And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Lisa Levin
Tuesday, December 05, 2023
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
Lara Goldstein
Merit Medical Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Lisa Levin
Show More